Vanguard Group Inc. Sells 846,891 Shares of Embecta Corp. $EMBC

Vanguard Group Inc. trimmed its holdings in Embecta Corp. (NASDAQ:EMBC) by 15.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,617,610 shares of the company’s stock after selling 846,891 shares during the quarter. Vanguard Group Inc. owned approximately 0.08% of Embecta worth $54,857,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of EMBC. Royal Bank of Canada boosted its position in shares of Embecta by 38.3% during the 1st quarter. Royal Bank of Canada now owns 18,201 shares of the company’s stock valued at $232,000 after acquiring an additional 5,036 shares during the last quarter. AQR Capital Management LLC boosted its position in shares of Embecta by 3.7% during the 1st quarter. AQR Capital Management LLC now owns 225,641 shares of the company’s stock valued at $2,738,000 after acquiring an additional 8,109 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Embecta by 2.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 49,323 shares of the company’s stock valued at $629,000 after acquiring an additional 1,159 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Embecta by 4.8% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 172,173 shares of the company’s stock valued at $2,195,000 after acquiring an additional 7,894 shares during the last quarter. Finally, Jane Street Group LLC boosted its position in shares of Embecta by 224.0% during the 1st quarter. Jane Street Group LLC now owns 132,688 shares of the company’s stock valued at $1,692,000 after acquiring an additional 91,729 shares during the last quarter. 93.83% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. BTIG Research downgraded Embecta from a “buy” rating to a “neutral” rating in a research report on Tuesday, May 5th. Weiss Ratings downgraded Embecta from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, May 6th. Wall Street Zen downgraded Embecta from a “strong-buy” rating to a “hold” rating in a research report on Saturday, May 9th. Zacks Research downgraded Embecta from a “hold” rating to a “strong sell” rating in a research report on Friday, May 8th. Finally, Mizuho lowered their target price on Embecta from $12.00 to $5.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. Two equities research analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Embecta has a consensus rating of “Reduce” and an average price target of $15.00.

Embecta Stock Performance

NASDAQ:EMBC opened at $3.14 on Friday. The stock’s fifty day moving average is $8.04 and its 200 day moving average is $10.63. Embecta Corp. has a fifty-two week low of $3.08 and a fifty-two week high of $15.55. The firm has a market capitalization of $186.29 million, a PE ratio of 1.65 and a beta of 1.09.

Embecta (NASDAQ:EMBC) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.42 by ($0.15). Embecta had a net margin of 10.73% and a negative return on equity of 23.96%. The company had revenue of $221.80 million for the quarter, compared to analysts’ expectations of $235.67 million. During the same quarter in the previous year, the company posted $0.70 EPS. The business’s quarterly revenue was down 14.4% on a year-over-year basis. Embecta has set its FY 2026 guidance at 1.550-1.75 EPS. Equities analysts forecast that Embecta Corp. will post 1.58 EPS for the current year.

Embecta Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Thursday, May 28th will be issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 1.3%. The ex-dividend date is Thursday, May 28th. Embecta’s dividend payout ratio is presently 2.11%.

Embecta Profile

Embecta Corp (NASDAQ: EMBC) is a pure-play diabetes care company that was spun off from Becton, Dickinson and Company on July 1, 2021. Headquartered in Franklin Lakes, New Jersey, Embecta focuses exclusively on the development, manufacturing and commercialization of products that enable insulin delivery and blood glucose monitoring for people with diabetes.

The company’s product portfolio includes insulin infusion sets, durable and patch pumps, pen needles, infusion tubing, blood glucose test strips, lancets and lancing devices.